Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Serologic surveillance of anthrax in the Serengeti ecosystem, Tanzania, 1996-2009.

Lembo T, Hampson K, Auty H, Beesley CA, Bessell P, Packer C, Halliday J, Fyumagwa R, Hoare R, Ernest E, Mentzel C, Mlengeya T, Stamey K, Wilkins PP, Cleaveland S.

Emerg Infect Dis. 2011 Mar;17(3):387-94. doi: 10.3201/eid1703.101290.

2.

Bacillus anthracis: interactions with the host and establishment of inhalational anthrax.

Passalacqua KD, Bergman NH.

Future Microbiol. 2006 Dec;1(4):397-415. Review.

PMID:
17661631
3.

Ante- and postmortem diagnostic techniques for anthrax: rethinking pathogen exposure and the geographic extent of the disease in wildlife.

Bagamian KH, Alexander KA, Hadfield TL, Blackburn JK.

J Wildl Dis. 2013 Oct;49(4):786-801. doi: 10.7589/2013-05-126. Review.

PMID:
24502707
4.

Detection technologies for Bacillus anthracis: prospects and challenges.

Rao SS, Mohan KV, Atreya CD.

J Microbiol Methods. 2010 Jul;82(1):1-10. doi: 10.1016/j.mimet.2010.04.005. Epub 2010 Apr 22. Review.

PMID:
20399814
5.

Bacillus anthracis: balancing innocent research with dual-use potential.

Hudson MJ, Beyer W, Böhm R, Fasanella A, Garofolo G, Golinski R, Goossens PL, Hahn U, Hallis B, King A, Mock M, Montecucco C, Ozin A, Tonello F, Kaufmann SH.

Int J Med Microbiol. 2008 Jul;298(5-6):345-64. doi: 10.1016/j.ijmm.2007.09.007. Epub 2008 Mar 28. Review.

PMID:
18375178
6.

Pathology of inhalational anthrax animal models.

Twenhafel NA.

Vet Pathol. 2010 Sep;47(5):819-30. doi: 10.1177/0300985810378112. Epub 2010 Jul 23. Review.

PMID:
20656900
7.

Anthrax toxin.

Bhatnagar R, Batra S.

Crit Rev Microbiol. 2001;27(3):167-200. Review.

PMID:
11596878
8.

Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.

Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG.

Expert Rev Anti Infect Ther. 2009 Mar;7(2):219-36. doi: 10.1586/14787210.7.2.219. Review.

PMID:
19254170
9.

[Current views on pathogenicity and immunogenicity factors of Bacillus anthracis].

Mikshis NI, Popov IuA, Kutyrev VV.

Zh Mikrobiol Epidemiol Immunobiol. 2010 May-Jun;(3):96-101. Review. Russian.

PMID:
20734727
10.

Anthrax undervalued zoonosis.

Fasanella A, Galante D, Garofolo G, Jones MH.

Vet Microbiol. 2010 Jan 27;140(3-4):318-31. doi: 10.1016/j.vetmic.2009.08.016. Epub 2009 Aug 18. Review.

PMID:
19747785
11.

The development of new vaccines against Bacillus anthracis.

Baillie L.

J Appl Microbiol. 2001 Oct;91(4):609-13. Review. No abstract available.

12.

[The return of anthrax. From bioterrorism to the zoonotic cluster of Sciacca district].

Scarlata F, Colletti P, Bonura S, Trizzino M, Giordano S, Titone L.

Infez Med. 2010 Jun;18(2):86-90. Review. Italian.

13.

Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.

Fukao T.

Lancet Infect Dis. 2004 Mar;4(3):166-70. Review.

PMID:
14998502
14.

Inhalational anthrax: epidemiology, diagnosis, and management.

Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA.

Chest. 1999 Nov;116(5):1369-76. Review.

PMID:
10559102
15.

[The epidemiology, epizootiology and prevention of anthrax in the former USSR].

Cherkasskiń≠ BL, Knop AG, Fedorov IuM, Sedov VA, Vedernikov VA, Pytalev PN.

Zh Mikrobiol Epidemiol Immunobiol. 1993 Sep-Oct;(5):117-21. Review. Russian. No abstract available.

PMID:
8067132
16.

[Progress on the vaccine for anthrax].

Zhan DW, Wang P, Wang LC, Zhang ZS.

Wei Sheng Wu Xue Bao. 2005 Feb;45(1):149-52. Review. Chinese.

PMID:
15847185

Supplemental Content

Support Center